Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gargon
2. Thiactin
3. Thiostrepton
1. Thiostrepton
2. Thiactin
3. 1393-48-2
4. Sr-05000001899
5. Ncgc00016576-01
6. Cas-1393-48-2
7. Prestwick2_000522
8. Dsstox_cid_20625
9. Dsstox_rid_79517
10. Dsstox_gsid_40625
11. Schembl25847
12. Bspbio_002468
13. Spectrum1505111
14. Chembl410968
15. Hms1569j05
16. Hms2093i06
17. Pharmakon1600-01505111
18. Tox21_110504
19. Nsc759821
20. Akos026750174
21. Ccg-213336
22. Nsc-759821
23. Ncgc00096010-01
24. Ncgc00096010-02
25. Sbi-0206784.p001
26. Ab01563039_01
27. Sr-05000001899-1
28. Sr-05000001899-3
29. Sr-05000001899-4
Molecular Weight | 1664.9 g/mol |
---|---|
Molecular Formula | C72H85N19O18S5 |
XLogP3 | 0.6 |
Hydrogen Bond Donor Count | 17 |
Hydrogen Bond Acceptor Count | 31 |
Rotatable Bond Count | 12 |
Exact Mass | 1663.4923528 g/mol |
Monoisotopic Mass | 1663.4923528 g/mol |
Topological Polar Surface Area | 701 Ų |
Heavy Atom Count | 114 |
Formal Charge | 0 |
Complexity | 3940 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 17 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Thiostrepton manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Thiostrepton, including repackagers and relabelers. The FDA regulates Thiostrepton manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Thiostrepton API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Thiostrepton supplier is an individual or a company that provides Thiostrepton active pharmaceutical ingredient (API) or Thiostrepton finished formulations upon request. The Thiostrepton suppliers may include Thiostrepton API manufacturers, exporters, distributors and traders.
click here to find a list of Thiostrepton suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Thiostrepton DMF (Drug Master File) is a document detailing the whole manufacturing process of Thiostrepton active pharmaceutical ingredient (API) in detail. Different forms of Thiostrepton DMFs exist exist since differing nations have different regulations, such as Thiostrepton USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Thiostrepton DMF submitted to regulatory agencies in the US is known as a USDMF. Thiostrepton USDMF includes data on Thiostrepton's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Thiostrepton USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Thiostrepton suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Thiostrepton as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Thiostrepton API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Thiostrepton as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Thiostrepton and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Thiostrepton NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Thiostrepton suppliers with NDC on PharmaCompass.
Thiostrepton Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Thiostrepton GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Thiostrepton GMP manufacturer or Thiostrepton GMP API supplier for your needs.
A Thiostrepton CoA (Certificate of Analysis) is a formal document that attests to Thiostrepton's compliance with Thiostrepton specifications and serves as a tool for batch-level quality control.
Thiostrepton CoA mostly includes findings from lab analyses of a specific batch. For each Thiostrepton CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Thiostrepton may be tested according to a variety of international standards, such as European Pharmacopoeia (Thiostrepton EP), Thiostrepton JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Thiostrepton USP).
LOOKING FOR A SUPPLIER?